Bandaram Pharma Packtech Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 365157,
    "name": "Bandaram Pharma",
    "stock_name": "Bandaram Pharma",
    "full_name": "Bandaram Pharma Packtech Ltd",
    "name_url": "stocks-analysis/bandaram-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "26.01",
    "chg": 0.51,
    "chgp": "2.0%",
    "dir": 1,
    "prev_price": "25.50",
    "mcapval": "46.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524602,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 26,
    "indexname": "",
    "isin": "INE875N01036",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "2 ",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/bandaram-pharma-365157-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Bandaram Pharma Packtech Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bandaram-pharma-packtech-faces-severe-selling-pressure-hits-lower-circuit-amid-distress-signals-3745827",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BandaramPharmaP_only_sellers_3745827.png",
        "date": "2025-12-04 09:35:13",
        "description": "Bandaram Pharma Packtech Ltd experienced a pronounced decline on 4 Dec 2025, marked by exclusive selling activity and a lower circuit scenario. The stock’s performance today starkly contrasts with broader market trends, signalling distress selling and a lack of buyer interest."
      },
      {
        "title": "Why is Bandaram Pharma falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-bandaram-pharma-fallingrising-3744954",
        "imagepath": "",
        "date": "2025-12-04 00:44:31",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Bandaram Pharma’s stock price has experienced notable volatility in recent sessions. Despite impressive returns over the past week and month, with gains of 40.00% and 62.45% respectively, the stock has reversed sharply in the last two days, losing nearly 19% in that period. This recent downturn culminated in a gap down opening on 03-Dec, where the stock began trading at ₹38.50, marking a near 10% drop from the previous close. Intraday, the price remained at this low level, indicating a lack of buying interest to support a rebound.</p>\n<p>The broader market, represented by the Sensex, has remained relatively stable during this time, with minor fluctuations of -0.59% over the past week and a modest 1.34% gain over the last month. This di..."
      },
      {
        "title": "How has been the historical performance of Bandaram Pharma?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-bandaram-pharma-3744729",
        "imagepath": "",
        "date": "2025-12-03 22:49:28",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Profit Growth</strong></p>\n<p>Bandaram Pharma’s consolidated net sales have nearly doubled from ₹18.73 crores in March 2023 to ₹36.96 crores in March 2025, reflecting a compound growth trend. This increase in sales was accompanied by a proportional rise in raw material costs, which grew from ₹16.05 crores to ₹30.96 crores over the same period. The company’s total operating income mirrored this growth, with no other operating income reported during these years.</p>\n<p>Operating profit before depreciation, interest, and tax (PBDIT) excluding other income remained stable at ₹2.82 crores in both March 2024 and March 2025, up from ₹1.16 crores in March 2023. Including other income, operating profit edged slightly higher to ₹2.91 crores in March 2025. Despite the rise in sales, the ope..."
      },
      {
        "title": "Bandaram Pharma Packtech Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bandaram-pharma-packtech-faces-severe-selling-pressure-hits-lower-circuit-amid-distress-signals-3743302",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BandaramPharmaP_only_sellers_3743302.png",
        "date": "2025-12-03 09:40:12",
        "description": "Bandaram Pharma Packtech Ltd has encountered significant selling pressure on 3 December 2025, with the stock hitting a lower circuit and exhibiting a complete absence of buyers. The healthcare services company’s shares opened sharply lower and have since traded at the day’s low, signalling distress selling and a challenging market environment."
      },
      {
        "title": "Bandaram Pharma Packtech Faces Intense Selling Pressure Amid Sharp Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bandaram-pharma-packtech-faces-severe-selling-pressure-hits-lower-circuit-amid-distress-signals-3740941",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BandaramPharmaP_only_sellers_3740941.png",
        "date": "2025-12-02 09:35:13",
        "description": "Bandaram Pharma Packtech Ltd experienced a significant downturn on 2 December 2025, with the stock plunging by 10.0% in a single trading session. The day was marked by extreme selling pressure, with no buyers recorded, signalling distress selling and a notable shift in market sentiment for the healthcare services company."
      },
      {
        "title": "Bandaram Pharma Packtech Surges with Unprecedented Buying Interest and Upper Circuit Lock",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bandaram-pharma-packtech-hits-upper-circuit-amid-unprecedented-buying-frenzy-3737759",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BandaramPharmaP_only_buyers_3737759.png",
        "date": "2025-12-01 09:40:09",
        "description": "Bandaram Pharma Packtech Ltd has witnessed extraordinary buying momentum, hitting the upper circuit with only buy orders in the queue. This rare market phenomenon highlights intense demand and a lack of sellers, signalling a potential multi-day circuit scenario for the healthcare services stock."
      },
      {
        "title": "Is Bandaram Pharma overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-bandaram-pharma-overvalued-or-undervalued-3736396",
        "imagepath": "",
        "date": "2025-11-29 08:14:43",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Understanding Bandaram Pharma’s Valuation Metrics</strong></p>\n<p>At a price of ₹39.60, Bandaram Pharma trades with a price-to-earnings (PE) ratio of 216.0, which is exceptionally high compared to typical industry standards. This elevated PE ratio suggests that investors are pricing in significant future growth or are willing to pay a premium for the company’s prospects. However, the company’s return on capital employed (ROCE) and return on equity (ROE) stand at a modest 3.88% and 1.72% respectively, indicating limited profitability relative to the capital invested.</p>\n<p>The price-to-book (P/B) ratio of 3.71 further highlights that the stock is valued well above its net asset value, while the enterprise value to EBITDA (EV/EBITDA) multiple of 30.28 also points to a premium valuation. The P..."
      },
      {
        "title": "Bandaram Pharma Packtech Surges with Unprecedented Buying Interest, Hits Upper Circuit",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bandaram-pharma-packtech-hits-upper-circuit-amid-unprecedented-buying-interest-3734885",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/BandaramPharmaP_only_buyers_3734885.png",
        "date": "2025-11-28 09:35:09",
        "description": "Bandaram Pharma Packtech Ltd witnessed extraordinary buying momentum on 28 Nov 2025, hitting the upper circuit with only buy orders in the queue. The stock opened sharply higher and maintained its peak price throughout the trading session, signalling robust demand and a potential multi-day circuit scenario."
      },
      {
        "title": "Bandaram Pharma Packtech Sees Shift in Market Assessment Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bandaram-pharma-packtech-stock-rating-upgraded-to-sell-on-technical-improvements-3734770",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/BandaramPharmaP_mojoScore_3734770.png",
        "date": "2025-11-28 08:09:39",
        "description": "Bandaram Pharma Packtech, a player in the healthcare services sector, has experienced a notable shift in market assessment driven by a combination of technical indicators and financial performance metrics. Despite recent price gains, the company’s long-term fundamentals and valuation present a complex picture for investors navigating the evolving healthcare equipment landscape."
      }
    ],
    "total": 128,
    "sid": "365157",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/bandaram-pharma-packtech-365157"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "30-Jan-2026",
      "details": "changes in management",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 30.01.2026",
      "datetime": "30-Jan-2026",
      "details": "Outcome of Board meeting held on 30.01.2026",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "10-Jan-2026",
      "details": "Certificate under Reg. 74(5) of SEBI (DP) Regulations 2018",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bandaram Pharma Packtech Ltd has declared <strong>1%</strong> dividend, ex-date: 22 Sep 25",
          "dt": "2025-09-22",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Bandaram Pharma Packtech Ltd has announced <strong>3:1</strong> rights issue, ex-date: 30 Jun 23",
          "dt": "2023-06-30",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Bandaram Pharma Packtech Faces Intense Selling Pressure Amid Consecutive Losses

2025-12-04 09:35:13

Bandaram Pharma Packtech Ltd experienced a pronounced decline on 4 Dec 2025, marked by exclusive selling activity and a lower circuit scenario. The stock’s performance today starkly contrasts with broader market trends, signalling distress selling and a lack of buyer interest.

Why is Bandaram Pharma falling/rising?

2025-12-04 00:44:31

Recent Price Movement and Market Context Bandaram Pharma’s stock price has experienced notable volatility in recent sessions. Despite impressive returns over the past week and month, with gains of 40.00% and 62.45% respectively, the stock has reversed sharply in the last two days, losing nearly 19% in that period. This recent downturn culminated in a gap down opening on 03-Dec, where the stock began trading at ₹38.50, marking a near 10% drop from the previous close. Intraday, the price remained at this low level, indicating a lack of buying interest to support a rebound. The broader market, represented by the Sensex, has remained relatively stable during this time, with minor fluctuations of -0.59% over the past week and a modest 1.34% gain over the last month. This di...

How has been the historical performance of Bandaram Pharma?

2025-12-03 22:49:28

Revenue and Profit Growth Bandaram Pharma’s consolidated net sales have nearly doubled from ₹18.73 crores in March 2023 to ₹36.96 crores in March 2025, reflecting a compound growth trend. This increase in sales was accompanied by a proportional rise in raw material costs, which grew from ₹16.05 crores to ₹30.96 crores over the same period. The company’s total operating income mirrored this growth, with no other operating income reported during these years. Operating profit before depreciation, interest, and tax (PBDIT) excluding other income remained stable at ₹2.82 crores in both March 2024 and March 2025, up from ₹1.16 crores in March 2023. Including other income, operating profit edged slightly higher to ₹2.91 crores in March 2025. Despite the rise in sales, the ope...

Bandaram Pharma Packtech Faces Intense Selling Pressure Amid Consecutive Losses

2025-12-03 09:40:12

Bandaram Pharma Packtech Ltd has encountered significant selling pressure on 3 December 2025, with the stock hitting a lower circuit and exhibiting a complete absence of buyers. The healthcare services company’s shares opened sharply lower and have since traded at the day’s low, signalling distress selling and a challenging market environment.

Bandaram Pharma Packtech Faces Intense Selling Pressure Amid Sharp Decline

2025-12-02 09:35:13

Bandaram Pharma Packtech Ltd experienced a significant downturn on 2 December 2025, with the stock plunging by 10.0% in a single trading session. The day was marked by extreme selling pressure, with no buyers recorded, signalling distress selling and a notable shift in market sentiment for the healthcare services company.

Bandaram Pharma Packtech Surges with Unprecedented Buying Interest and Upper Circuit Lock

2025-12-01 09:40:09

Bandaram Pharma Packtech Ltd has witnessed extraordinary buying momentum, hitting the upper circuit with only buy orders in the queue. This rare market phenomenon highlights intense demand and a lack of sellers, signalling a potential multi-day circuit scenario for the healthcare services stock.

Is Bandaram Pharma overvalued or undervalued?

2025-11-29 08:14:43

Understanding Bandaram Pharma’s Valuation Metrics At a price of ₹39.60, Bandaram Pharma trades with a price-to-earnings (PE) ratio of 216.0, which is exceptionally high compared to typical industry standards. This elevated PE ratio suggests that investors are pricing in significant future growth or are willing to pay a premium for the company’s prospects. However, the company’s return on capital employed (ROCE) and return on equity (ROE) stand at a modest 3.88% and 1.72% respectively, indicating limited profitability relative to the capital invested. The price-to-book (P/B) ratio of 3.71 further highlights that the stock is valued well above its net asset value, while the enterprise value to EBITDA (EV/EBITDA) multiple of 30.28 also points to a premium valuation. The P...

Bandaram Pharma Packtech Surges with Unprecedented Buying Interest, Hits Upper Circuit

2025-11-28 09:35:09

Bandaram Pharma Packtech Ltd witnessed extraordinary buying momentum on 28 Nov 2025, hitting the upper circuit with only buy orders in the queue. The stock opened sharply higher and maintained its peak price throughout the trading session, signalling robust demand and a potential multi-day circuit scenario.

Bandaram Pharma Packtech Sees Shift in Market Assessment Amid Mixed Financial and Technical Signals

2025-11-28 08:09:39

Bandaram Pharma Packtech, a player in the healthcare services sector, has experienced a notable shift in market assessment driven by a combination of technical indicators and financial performance metrics. Despite recent price gains, the company’s long-term fundamentals and valuation present a complex picture for investors navigating the evolving healthcare equipment landscape.

View All News